- Home
- SRPT vs RVPHW Comparison
SRPT vs RVPHW Comparison
Compare SRPT & RVPHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- RVPHW
- Stock Information
- Founded
- SRPT 1980
- RVPHW 2018
- Country
- SRPT United States
- RVPHW United States
- Employees
- SRPT N/A
- RVPHW 14
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- RVPHW Biotechnology: Pharmaceutical Preparations
- Sector
- SRPT Health Care
- RVPHW Health Care
- Exchange
- SRPT Nasdaq
- RVPHW Nasdaq
- Market Cap
- SRPT N/A
- RVPHW N/A
- IPO Year
- SRPT 1997
- RVPHW N/A
- Fundamental
- Price
- SRPT $20.28
- RVPHW $0.06
- Analyst Decision
- SRPT Buy
- RVPHW
- Analyst Count
- SRPT 26
- RVPHW 0
- Target Price
- SRPT $70.92
- RVPHW N/A
- AVG Volume (30 Days)
- SRPT 6.5M
- RVPHW 22.4K
- Earning Date
- SRPT 08-06-2025
- RVPHW 03-14-2025
- Dividend Yield
- SRPT N/A
- RVPHW N/A
- EPS Growth
- SRPT N/A
- RVPHW N/A
- EPS
- SRPT N/A
- RVPHW N/A
- Revenue
- SRPT $2,233,371,000.00
- RVPHW N/A
- Revenue This Year
- SRPT $26.87
- RVPHW N/A
- Revenue Next Year
- SRPT $3.15
- RVPHW N/A
- P/E Ratio
- SRPT N/A
- RVPHW N/A
- Revenue Growth
- SRPT 59.15
- RVPHW N/A
- 52 Week Low
- SRPT $18.30
- RVPHW $0.13
- 52 Week High
- SRPT $173.25
- RVPHW $0.15
- Technical
- Relative Strength Index (RSI)
- SRPT 20.82
- RVPHW N/A
- Support Level
- SRPT $18.30
- RVPHW N/A
- Resistance Level
- SRPT $22.98
- RVPHW N/A
- Average True Range (ATR)
- SRPT 2.20
- RVPHW 0.00
- MACD
- SRPT -1.46
- RVPHW 0.00
- Stochastic Oscillator
- SRPT 8.90
- RVPHW 0.00
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.